GE HealthCare Technologies GEHC Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 39.1%-2.9pp | 40%-1.7pp | 40.8%-0.5pp | 41.6%+0.6pp | 42%+1.3pp | |
| Operating margin | 12.6%-1.1pp | 13.4%+0.1pp | 13.5%+0.7pp | 13.8%+1.2pp | 13.7%+1.3pp | |
| Net margin | 9.1%-1.9pp | 10.1%0.0pp | 11%+2.4pp | 11.2%+3.1pp | 11%+3.0pp | |
| Returns | ||||||
| Return on equity | 19.2%-7.1pp | 22.2%-3.4pp | 24.2%+2.5pp | 25.6%+4.4pp | 26.3%+4.0pp | |
| Return on invested capital | 10.2%-2.2pp | 11.1%-0.9pp | 11.3%+1.3pp | 12.1%+2.4pp | 12.5%+2.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.2×+0.2× | 1.4×+0.3× | 1.2×0.0× | 1.2×+0.1× | 1×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 1×0.0× | 1×-0.1× | 1.1×-0.2× | 1.1×-0.1× | 1×-0.3× | |
| Net debt / EBITDA | 3.3×+0.5× | 3.1×+0.2× | 3.2×-0.2× | 3.2×+0.1× | 2.8×-0.4× | |
| Per Share | ||||||
| Book value per share | $23.34+16.6% | $22.66+23.2% | $21.87+20.7% | $21.21+24.8% | $20.02+24.0% | |
| Valuation | ||||||
| Market capitalization | $32.48B-12.0% | $37.36B+4.6% | $34.29B-20.1% | $32.96B-7.2% | $36.91B-11.0% | |
| Price / earnings | 17×+0.1× | 17.9×0.0× | 15.5×-10.1× | 14.7×-7.8× | 16.9×-9.5× | |
| Price / sales | 1.5×-0.3× | 1.8×0.0× | 1.7×-0.5× | 1.7×-0.2× | 1.9×-0.3× | |
| Price / book | 3×-1.0× | 3.6×-0.6× | 3.4×-1.7× | 3.4×-1.2× | 4×-1.6× | |
| EV / EBITDA | 13.3×-0.8× | 14.3×+0.2× | 13.6×-3.7× | 13.1×-1.7× | 14×-2.9× | |
| Dividend yield | 0.2%0.0pp | 0.2%0.0pp | 0.2%+0.1pp | 0.2%0.0pp | 0.2%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GE HealthCare Technologies's profit margins?
- GE HealthCare Technologies (GEHC) runs a 39.1% gross margin and a 12.6% operating margin, with a 9.1% net margin.
- Where do GE HealthCare Technologies's ratios come from?
- Every ratio is computed from GE HealthCare Technologies's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
